Home › Calculator › CBIO Dividend Calculator 2026
CBIO Dividend Calculator 2026
No dividendHealthcareCrescent Biopharma, Inc. · NASDAQ
Price: $12.82 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
CBIO is not a dividend-focused stock
CBIO pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
CBIO Dividend Yield
Crescent Biopharma, Inc. (CBIO) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CBIO pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Crescent Biopharma, Inc. (CBIO) — Dividend Analysis 2026
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
CBIO Dividend & DRIP — Frequently Asked Questions
Does CBIO pay a dividend?
No. Crescent Biopharma, Inc. (CBIO) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of CBIO?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does CBIO have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. CBIO has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to CBIO
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CBIO DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CBIO position with:
🌍 CBIO Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CBIO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CBIO Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CBIO Dividend Payment Schedule
CBIO pays quarterly — 4 times per year. Ex-div: —.
📊 CBIO vs Healthcare Benchmarks
How CBIO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CBIO sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CBIO Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-09-16 | 240 | $17.90 | $4.3K | ||
| Sale | 2026-09-16 | 658 | $17.90 | $11.8K | ||
| Sale | 2026-09-16 | 623 | $17.90 | $11.2K | ||
| Sale | 2026-09-16 | 568 | $17.90 | $10.2K | ||
| Sale | 2026-09-16 | 620 | $17.90 | $11.1K | ||
| Sale | 2026-09-16 | 1,610 | $17.90 | $28.8K | ||
| Sale | 2026-09-18 | 7,837 | $16.71 | $131.0K | ||
| Sale | 2026-09-16 | 731 | $17.90 | $13.1K | ||
| Sale | 2026-09-18 | 3,839 | $16.71 | $64.2K | ||
| Buy | 2026-07-16 | 853,450 | $14.50 | $12.38M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare CBIO with peers: CBIO vs ARMP · CBIO vs CCCC · CBIO vs CGEN
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CBIO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Crescent Biopharma, Inc. (CBIO) is currently trading at $12.82, 53% below its 52-week high. It does not currently pay a regular dividend.
Does CBIO Pay a Dividend? Crescent Biopharma, Inc. Dividend Status
Crescent Biopharma, Inc. (CBIO) is a healthcare stock trading at $12.82. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CBIO News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your CBIO DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.